Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation

Transplantation

Volumn 80, Issue 9, 2005, Pages 1349-1352

  Baggio, Bruno ^a,b   Budakovic, Alessandro ^a   Ferraro, Alberto ^a   Checchetto, Simone ^a   Priante, Giovanna ^a   Musacchio, Estella ^a   Manzato, Enzo ^a   Zaninotto, Martina ^b   Maresca, Maria Cristina ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Treviso Hospital   (Italy)

Author keywords

Bone disease; Phospholipid polyunsaturated fatty acid; Renal transplantation

Indexed keywords

ARACHIDONIC ACID; BIOCHEMICAL MARKER; ICOSAPENTAENOIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE METABOLISM; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FEMUR NECK; FOLLOW UP; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIPID COMPOSITION; LONGITUDINAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; ARACHIDONIC ACID; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES; BONE REMODELING; CYCLOSPORINE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FEMUR NECK; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHOSPHOLIPIDS; TACROLIMUS;

EID: 28544436640     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000179152.57167.c1     Document Type: Article

References (20)

1. Baggio B. Fatty acids, calcium and bone metabolism. J Nephrol 2002; 15: 601.
2. Baggio B, Budakovic A, Nassuato MA, et al. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000; 8: 1278.
3. Priante G, Bordin L, Musacchio E, et al. Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid. Clin Sci 2002; 102: 403.
4. Priante G, Musacchio E, Pagnin E, et al. Specific effect of arachidonic acid on inducible nitric oxide synthase (iNOS) mRNA expression in human osteoblastic cells. Clin Sci 2005; 109: 177.
5. Heaf JG. Bone disease alter renal transplantation. Transplantatio 2003; 75: 315.
6. Montalban C, De Francisco AL, Marinoso ML, et al. Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int 2003; 63: 129.
7. Rojas E, Carlini RG, Clesca P, et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodelling. Kidney Int 2003; 63: 1915.
8. Kobashigawa JA, Kasiske BL. Hyperlipidemia in solid organ transplantation. Transplantation 1997; 63: 331.
9. Charco R. Dyslipemia and long-term immunosuppression. Transplant Proc 2002; 34: 124.
10. Djamali A, Premasathian N, Pirsch JD. Outcomes in kidney transplantation. Semin Nephrol 2003; 23: 306.
11. Cofan F, Zambon D, Rodriguez C, et al. Fatty acid composition in low-density lipoprotein from renal transplant recipients. Transplant Proc 1999; 31: 2330.
12. Cofan F, Zambon D, Laguna JC, et al. Fatty acid composition in low-density lipoprotein from renal transplant recipients treated with cyclosporine. Transplant Proc 2002; 34: 374.
13. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta 6, delta 5, and delta 9 desaturases. Annu Rev Nutr 2004; 24: 345.
14. de Alaniz MJ, Marra CA. Glucocorticoid and mineralcorticoid hormones depress liver delta 5 desaturase activity through different mechanisms. Lipids 1992; 27: 599.
15. de Gomez Dumm IN, Raimondi C, Touceda L, Fassit JC. Effect of methyl-prednisone and cyclosporine on the lipid pattern and polyunsaturated fatty acid biosynthesis in the rats. Acta Physiol Pharmacol Ther Latinoam 1999; 49: 124.
16. Mills DE, de Antueno R, Scholey J. Interaction of dietary fatty acids and cyclosporine A in the borderline hypertensive rat: tissue fatty acids. Lipids 1994; 29: 27.
17. Pompeo A, Baldassare M, Luini A, Buccione R. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitari corticotrope tumor cells. Life Sciences 1999; 64: 837.
18. Attur MG, Patel R, Thakker G, et al. Differential anti-inflamamtory effects of immunosuppressive drugs: cyclosporine, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm Res 2000; 49: 20.
19. Bellorin-Font E, Rojas E, Carlini RG, et al. Bone remodeling after renal transplantation. Kidney Int 2003; S85: 125.
20. Goffin E, Devogelaer JP, Depresseux G, et al. Evaluation of bone mineral density after transplantation under a tacrolimus-based immunosuppression: a pilot study. Clin Nephrol 2003; 59: 190.